Pfizer settles with victims of Nigerian drug trialBMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d5268 (Published 16 August 2011) Cite this as: BMJ 2011;343:d5268
- Jeanne Lenzer
- 1New York
The drug company Pfizer has paid out $175 000 (£107 000; €120 000) to each of four families whose children died during a study of an experimental antibiotic in Kano, Nigeria. But the settlement has been strongly criticised by the families involved and by a leading ethicist in the United States, where Pfizer has its headquarters.
The study was conducted during a deadly outbreak of meningitis in 1996, when some 200 children were enrolled in the study. Half were given Pfizer’s experimental antibiotic, trovafloxacin (which it markets as Trovan), and half were given ceftriaxone. Five children died in the trovafloxacin arm and six in the ceftriaxone arm. Pfizer has not reported on the outcomes of 10 of the children.
The families …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial